MRNA Competitors & Alternatives
Compare Moderna Inc with similar stocks in the same industry
Biotechnology
MRNA
Main Stock$58.07
Tradestie Score
52
Market Cap
$10.74B
Revenue Growth
2.6%
Analyst Upside
-16.6%
Top Competitors
232 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
INSM
Insmed, Inc.
|
$106.64
|
$31.13B | - | 45 | Compare |
|
BNTX
BioNTech SE American Depositary Share
|
$91.83
|
$24.57B | - | 51 | Compare |
|
ZM
Zoom Communications, Inc. Class A Common Stock
|
$85.81
|
$24.33B | 13.4 | 50 | Compare |
|
GMAB
Genmab A/S ADS
|
$28.85
|
$19.56B | 21.2 | 56 | Compare |
|
NIO
NIO Inc. American depositary shares, each representing one Class A ordinary share
|
$4.67
|
$18.85B | - | 59 | Compare |
|
INCY
Incyte Genomics Inc
|
$115.79
|
$16.93B | 16.3 | 57 | Compare |
|
RPRX
Royalty Pharma plc Class A Ordinary Shares
|
$58.72
|
$15.70B | 30.1 | 59 | Compare |
|
SMMT
Summit Therapeutics Inc. Common Stock
|
$14.74
|
$15.22B | - | 54 | Compare |
|
ASND
Ascendis Pharma A/S American Depositary Shares
|
$251.93
|
$12.36B | 29.6 | 50 | Compare |
|
EXEL
Exelixis Inc
|
$54.98
|
$11.09B | 18.6 | 50 | Compare |
More MRNA Analysis
Data updated: Jul 23, 2026 | Industry: Biotechnology (SIC 2836)
232 stocks in this industry